WASHINGTON, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Dermal Fillers Market finds that the increasing need for minimally invasive cosmetic procedures is expediting market growth. In addition, increasing awareness & the need for aesthetic beauty and launching new products are anticipated to augment the Global Dermal Fillers Market expansion during the forecast period.
The Global Dermal Fillers Market revenue is expected to reach a value USD 7.9 Billion in 2028.
The Global Market revenue was valued at USD 4.7 Billion in 2021 and is expected to grow to exhibit a Compound Annual Growth Rate (CAGR) of 9.2% during the forecast period; states Vantage Market Research, in a report, titled “Dermal Fillers Market Size, Share & Trends Analysis Report by Product (Biodegradable, Non-Biodegradable), by Material type (Hyaluronic Acid (HA), Calcium Hydroxylapatite (CaHA), Poly-L-Lactic Acid, Polymethyl-Methacrylate Microspheres (PMMA), by Application (Facial Line Correction, Face Lift, Lip Enhancement), by End-use (Dermatology Clinics, Hospitals, Others), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)”.
Key Industry Findings & Insights from the report:
The global Dermal Fillers Market was valued USD 4.7 Billion in 2021 and is all set to surpass USD 7.9 Billion by 2028, exhibiting a CAGR of 9.2% during the forecast period 2022-2028.
In terms of revenue, the application segment held the largest revenue share of in 2021 and is estimated to maintain its dominance for the forecast period.
In terms of revenue, the product segment held the second largest market share of in 2021 and is estimated to grow rapidly during the forecast period.
The growth can be attributed to rapid urbanization, technological advancement, an increase in investment by developing countries.
North America captured the lion share in 2021 and is projected to retain its position over the forecast period. This can be attributed to the existence of a significant number of Dermal Fillers industry companies and the high adoption rate owing to government measures that stimulate this industry in this region. The growth is primarily due to the increasing collaborations.
Get Access to a Free Copy of Our Latest Sample Report @ https://www.vantagemarketresearch.com/dermal-fillers-market-1793/request-sample
Rising Preference in Favor of Minimally Invasive Cosmetic Methods to Drive the Market Growth
The adoption of minimally invasive procedures has been growing across the globe lately. The minimally invasive surgery provides numerous benefits to patients, such as fewer incisions, quicker recovery times, and less pain and scarring. As a result, many minimally invasive dermatological methods are being advanced for facial rejuvenation. First, the injectable Dermal Fillers Market is injected into the upper dermis layers to treat the superficial fine wrinkles or subcutaneous space for facial volume growth. Then, Dermal Fillers Market are placed slowly and steadily, filling central folds, which leads to the natural, long-lasting result. Moreover, age also plays an essential part in defining the specific requirements of medical esthetic methods, where adults often ask for minimally invasive procedures. In addition, the population aged between 35-55 chooses minimally invasive aesthetic techniques over surgery.
A surge in Need for Dermal Fillers Market Procedures and Growing R&D Inventiveness to Stimulate Market Growth
The high demand for Dermal Fillers Market worldwide is a significant factor propelling the global Dermal Fillers Market development. In addition, there is a rise in research and development initiatives in the Dermal Fillers Market business, along with the latest regulatory approvals specified. As a result, this positively influences the Dermal Fillers Market industry. Also, the high proportion of the grown-up population and the growing pattern of early aging because of environmental conditions like pollution is accountable for the market growth.
Furthermore, the Dermal Fillers Market industry has promising growth during the forecast period due to its less painful technique to treat different problems regarding the facial skin, less scarring and need for more minor cuts, lesser pain, and low rate of ailment that happen post-surgery. Similarly, expanding elderly population has also resulted in a surge in demand for anti-aging treatment. Besides, this treatment is helpful in the rejuvenation of skin and restoring lost collagen from the body. Also, the rise in non-surgical technologies and the latest treatment options have made aesthetics easier to get to wide-ranging patients. Therefore, the Dermal Fillers Market is not restricted only to the facial skin methods, but it comprises the treatment that involves aesthetically transforming body parts.
Purchase This Premium Report (Price 4500 USD for a single-user license) at @ https://www.vantagemarketresearch.com/buy-now/dermal-fillers-market-1793/0
Benefits of Purchasing Dermal Fillers Market Reports:
Customer Satisfaction: Our sales team of experts will available for you 24/7.
Analyst Support: Speak to our analyst about your questions before or after purchasing the report.
Assured Quality: Focuses on perfection and quality of reports.
Incomparable Skills: Our Analysts in-depth insights are beyond comparison.
The report on Dermal Fillers Market highlights:
Historic Data, Estimates, and Forecast
Read Full Research Report @ https://www.vantagemarketresearch.com/industry-report/dermal-fillers-market-1793
North America Leading the Global Dermal Fillers Market
In terms of region, North America dominated the Global Dermal Fillers Market in and will continue its dominance throughout the forecast period. This is because of the high disposable income of people and the growing usage of fillers in this region. In addition, the stringent rules & regulations related to new products will likely fuel regional market growth. Moreover, the rising adoption of facial procedures with injectables, the mounting population that spends on aesthetic procedures, and the increase in product availability with the expanding approvals by the U.S. FDA are other vital factors that will probably drive the Dermal Fillers Market industry in the region during the forecast timeframe.
List of Prominent Players in Dermal Fillers Market:
Merz Pharma GmbH & Co. KGaA.
Huons Global Co. Ltd. (Humedix)
Shanghai Bioha Technology Co. Ltd
Zhejiang Jingjia Medical Technology Co. Ltd.
Browse market data Tables and Figures spread through 144 Pages and in-depth TOC on "Dermal Fillers Market Size, Share & Trends Analysis Report by Product (Biodegradable, Non-Biodegradable), by Material type (Hyaluronic Acid (HA), Calcium Hydroxylapatite (CaHA), Poly-L-Lactic Acid, Polymethyl-Methacrylate Microspheres (PMMA)), by Application (Facial Line Correction, Face Lift, Lip Enhancement), by End-use (Dermatology Clinics, Hospitals, Others), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)".
February 2021: Coll Plant Biotechnologies with Allergan Aesthetics, an AbbVie Company, announced entering the global exclusive development and commercialization agreement for dermal & soft tissue filler products. Coll Plant has granted Allergan Aesthetics worldwide exclusivity to use its plant-derived recombinant human collagen (rhCollagen) with Allergan Aesthetics' proprietary technologies for the manufacture and commercialization of dermal & soft tissue fillers.
January 2021: Merz Aesthetics, the world’s largest committed medical aesthetics industry, and Candela Corporation, the leading global medical aesthetic device business, introduced a commercial collaboration to create an extensive medical aesthetics portfolio worldwide. In addition, this will help the companies to expand their device, injectable, and skincare portfolios worldwide, offering customers easy access to complete offerings for products & support services.
Key Questions Answered in The Report:
Which region will show the fastest and highest growth in the near future?
Which are the top five players and their weakness and strength of the Market?
What will be the future innovation in the upcoming six years?
Which application and product will lead the largest share of the Market?
What are the growth drivers, restraints and challenges of the industry?
What will be the CAGR and size of the Dermal Fillers Market for the base year and forecast period?
This market titled “Dermal Fillers Market” will cover exclusive information in terms of Regional Analysis, Forecast, and Quantitative Data – Units, Key Market Trends, and various others as mentioned below:
Market Size Provided for Years
• Product • Biodegradable • Non-Biodegradable • Material Type • Hyaluronic Acid • Calcium Hydroxylapatite • Poly-L-Lactic Acid • Polymethyl-Methacrylate Microspheres • Other Material Types • Application • Facial Line Correction • Face Lift • Lip Enhancement • Other Applications • End-Use • Dermatology Clinics • Hospitals • Other End Uses • Region • North America • Europe • Asia Pacific • Latin America • Middle East & Africa
• North America • U.S. • Canada • Mexico • Europe • U.K • France • Germany • Italy • Spain • Rest Of Europe • Asia Pacific • China • Japan • India • South Korea • South East Asia • Rest Of Asia Pacific • Latin America • Brazil • Argentina • Rest Of Latin America • Middle East & Africa • GCC countries • South Africa • Rest Of Middle East & Africa
• AbbVie Inc. (Allergan) • Merz Pharma GmbH & Co. KGaA. • Galderma S.A • Croma Pharma GmbH. • Cytophil Inc. • Huons Global Co. Ltd. (Humedix) • Prollenium Medical Technologies • Shanghai Bioha Technology Co. Ltd • Sinclair Pharma • Teoxane Laboratories • Zhejiang Jingjia Medical Technology Co. Ltd.
Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis
The report can be customized as per client needs or requirements. For any queries, you can contact us on sales@vantagemarketresearch.com or +1 (202) 380-9727. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.
Mental Health Apps Market Size, Share & Trends Analysis Report by Platform Type (iOS, Android, Other Platforms), by Application Type (Depression & Anxiety Management, Meditation Management, Stress Management, Wellness Management), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028).
Injectable Drug Delivery Market Size, Share & Trends Analysis Report by Type (Devices, Formulations), by Formulation Packaging (Ampules, Vials, Cartridges, Bottles), by Application (Auto-Immune Diseases, Hormonal Disorders, Orphan Diseases, Oncology), by Usage Pattern (Curative Care, Immunization), by Site of Administration (Skin, Circulatory/Musculoskeletal, Organs, Central Nervous System), by Distribution Channel (Hospitals, Retail Pharmacy Stores), by Facility of Use (Hospitals & Clinics, Home Care Settings), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028).
Cat Allergy in Humans Market Size, Share & Trends Analysis Report by Treatment (Antihistamines, Corticosteroid Nasal Sprays, Decongestants, Leukotriene Inhibitors), by Application (Allergy Treatment, Allergy Prevention), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028).
Accountable Care Solutions Market Size, Share & Trends Analysis Report by Product & Service (Healthcare Provider Solutions, Healthcare Payer Solutions, Services), by Delivery Mode (Web & Cloud-Based Delivery Mode, On-Premise Delivery Mode), by End User (Healthcare Providers, Healthcare Payers), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028).
Top Companies in Dermal Fillers Market | Key Players Market Size and Share, Growth Analysis, Supply and Demand, Price Analysis.
We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research reports. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.
Follow Us on LinkedIn: https://www.linkedin.com/company/vantage-market-research/
Follow Us on Twitter: https://twitter.com/vantagemarketr
Follow Us on Facebook: https://www.facebook.com/vantagemarketresearch
6218 Georgia Avenue NW Ste 1 - 564
Website: https://www.vantagemarketresearch.com/
Latest Vantage Market Research Press Releases @https://www.vantagemarketresearch.com/insight/press-releases
Latest Vantage Market Research Blog @ https://www.vantagemarketresearch.com/insight/blogs
Yahoo Finance Live anchors discuss stock performance for FedEx.
There was a sell-off in cardboard packaging stocks this morning, with shares of International Paper (NYSE: IP) down 9.4% at 10:30 a.m. ET on Friday, Packaging Corporation of America (NYSE: PKG) shares down 9.7%, and the stock of WestRock (NYSE: WRK) down 9.8%. Shares of FedEx (NYSE: FDX) plunged more than 22% this morning after the company issued an earnings warning predicated on softening global volume. The volume FedEx referred to was the number of packages wrapped in cardboard and shipped to customers.
Warren Buffett, Berkshire Hathaway's (NYSE: BRK.A)(NYSE: BRK.B) chief executive officer and chairman, has been investing since the age of 11. With his net worth at nearly $100 billion, the understatement of the century would be to say that Buffett knows a thing or two about investing. This is why it's worth paying attention to the holdings within Berkshire Hathaway's $344 billion investment portfolio.
In this article, we discuss 10 high-yield dividend stocks for stable income. You can skip our detailed analysis of dividend stocks and their performance in the past, go directly and read 5 High-Yield Dividend Stocks for Stable Income. Dividend-paying stocks are gaining traction this year as investors look for cash during difficult times. Blue chip stable […]
As bad the news was for FedEx, it may be worse news for the U.S. economy --- and an early sign of a recession.
Electric vehicle (EV) stocks have gotten a lot of attention over the last few years as production has increased and multiple companies have come public, but that doesn't mean all EV stocks are good investments. Companies still have to make money building and selling vehicles, which has historically been the hardest part of the auto business. Given the current trends, I think General Motors (NYSE: GM) is the one EV stock to buy hand over fist, while ChargePoint (NYSE: CHPT) and Canoo (NASDAQ: GOEV) have some serious red flags.
Intel (INTC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Struggling Bed Bath & Beyond Inc. releases a list of dozens of stores it aims to close. Most of the stores on this list will close by the end of the month.
Central banks are like “reformed smokers,” famed investor Stanley Druckenmiller says. “They’ve gone from printing a bunch of money, like driving a Porsche at 200 miles an hour, to not only taking the foot off the gas, but just slamming the brakes on.”
Recent developments suggest business trends are getting worse---not better, meaning there could be more downside ahead.
(Bloomberg) -- Wall Street analysts didn’t mince words in discussing FedEx Corp.’s forecast for the current quarter -- which missed by a landslide -- and its withdrawal of full-year guidance. It’s really bad.Most Read from BloombergGermany Tightens Control Over Industry With Russian Oil GrabJeff Bezos Loses Spot as World’s Second Richest Person to Gautam AdaniPatagonia Billionaire Who Gave Up Company Skirts $700 Million Tax HitAdobe Near Deal for Online Design Startup Figma, Sources SayPutin Ack
Warren Buffett's Berkshire Hathaway bought a bunch of stocks during the second quarter. Notable names included Apple (NASDAQ: AAPL), Activision Blizzard (NASDAQ: ATVI), Occidental Petroleum (NYSE: OXY), and Chevron (NYSE: CVX). Buffett seems to be most bullish on Apple and Occidental Petroleum.
Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap Pharmaceuticals industry, AbbVie (ABBV), Novartis (NVS), Merck (MRK) and AstraZeneca (AZN) are worth retaining in your portfolio.
Netflix (NFLX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Stubborn inflationary pressures and a hangover from a prior week's announcement hurt Beyond Meat shares this week.
In this article, we will look at stocks that Dan Loeb is buying for the rest of 2022. If you want to explore more stocks that Dan Loeb is buying, you can also take a look at Dan Loeb is Buying These 3 Stocks for the Rest of 2022. In 1995, Dan Loeb borrowed $3.3 […]
After three months of highly volatile trading, which have seen the S&P 500 drop down toward 3,600, rally up to 4,300, and fall back down to 3,900, investors can be forgiven for feeling some whiplash. The question that needs answering, however, is where will the markets go from here? Morgan Stanley strategist Andrew Slimmon believes that investors shouldn’t worry too much about the bear case. Worse-than-expected inflation numbers for August may have pushed the markets into a tumble this week, but
You can't guess the bottom. But a bargain is a bargain.
It's no secret that investors are worried about runaway inflation. Cathie Wood and Elon Musk see deflation as the bigger threat.
A rally might return to Tesla stock, contends Deutsche Bank. Here's the call.